Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.31
0.00 (-0.07%)
Apr 29, 2026, 3:13 PM EDT - Market open
Kezar Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 54 | 46 | 49 | 69 | 481 | 822 | |
| Market Cap Growth | 87.01% | -6.05% | -28.81% | -85.69% | -41.42% | 240.23% | |
| Enterprise Value | -16 | -34 | -82 | -130 | 204 | 706 | |
| Last Close Price | 7.31 | 6.29 | 6.72 | 9.47 | 70.40 | 167.20 | |
| PS Ratio | - | - | - | 9.84 | - | - | |
| PB Ratio | 0.76 | 0.66 | 0.42 | 0.37 | 1.78 | 4.17 | |
| P/TBV Ratio | 0.77 | 0.66 | 0.42 | 0.37 | 1.78 | 4.17 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.14 | 0.10 | 0.08 | 0.07 | |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -0.99 | -0.97 | -0.95 | -0.99 | |
| Net Debt / EBITDA Ratio | 1.35 | 1.35 | 1.32 | 1.75 | 3.64 | 3.66 | |
| Net Debt / FCF Ratio | 1.34 | 1.34 | 1.56 | 2.19 | 4.22 | 4.55 | |
| Asset Turnover | - | - | - | 0.03 | - | - | |
| Quick Ratio | 11.23 | 11.23 | 6.53 | 11.48 | 25.22 | 25.37 | |
| Current Ratio | 11.52 | 11.52 | 6.76 | 11.66 | 25.98 | 25.77 | |
| Return on Equity (ROE) | -59.93% | -59.93% | -55.00% | -44.54% | -29.24% | -32.34% | |
| Return on Assets (ROA) | -29.52% | -29.52% | -30.45% | -25.26% | -17.19% | -18.48% | |
| Return on Capital Employed (ROCE) | -74.60% | -74.60% | -71.70% | -51.70% | -24.70% | -26.10% | |
| Earnings Yield | -103.90% | -121.65% | -170.78% | -147.92% | -14.18% | -6.65% | |
| FCF Yield | -96.02% | -112.42% | -151.42% | -121.18% | -12.55% | -5.20% | |
| Buyback Yield / Dilution | -0.36% | -0.36% | -0.48% | -7.70% | -27.69% | -19.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.